英國(guó)HIV協(xié)會(huì)(BHIVA)和歐洲艾滋病臨床學(xué)會(huì)(EACS)的官方期刊。一個(gè)新的廣泛的基礎(chǔ)上的研究人員和臨床醫(yī)生負(fù)責(zé)治療艾滋病毒陽(yáng)性患者。該雜志將以原創(chuàng)文章、案例報(bào)告和評(píng)論為特色。還將包括一個(gè)討論倫理問(wèn)題及其對(duì)臨床管理的影響的常規(guī)章節(jié)。所有文章都將經(jīng)過(guò)同行評(píng)審。爆發(fā)以來(lái)的艾滋病毒流行的論文數(shù)量寫在這個(gè)問(wèn)題上已經(jīng)上升指數(shù)和臨床醫(yī)生試圖治療HIV-seropositive患者面臨一系列令人眼花繚亂的信息包括病毒學(xué)免疫學(xué)和流行病學(xué)和試圖解釋患者最佳治療的影響。因此我們希望產(chǎn)生一個(gè)基本的科學(xué)》雜志上提出了一個(gè)格式,將能為醫(yī)生治療HIV-seropositive患者整個(gè)歐洲,在適當(dāng)?shù)臅r(shí)候?qū)⒈灰暈橐粋€(gè)重要的出版物的最新研究和臨床發(fā)現(xiàn)艾滋病毒藥物。

The official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS). A new broad based journal for researchers and clinicians with responsibility for treating HIV seropositive patients. The Journal will feature original articles case reports and reviews. A regular section addressing ethical issues and their implications for clinical management will also be included. All articles will be peer-reviewed. Since the onset of the HIV epidemic the number of papers written on this subject has risen exponentially and clinicians trying to treat HIV-seropositive patients are faced with a bewildering array of information including virology immunology and epidemiology and have to try to explain to their patients the implications of this for optimum treatment. We therefore hope to produce a journal in which basic science is presented in a format that will be readily accessible to physicians treating HIV-seropositive patients across Europe and which in due course will be seen as one of the premier publications for the latest research and clinical findings in HIV medicine.